
In a recent study, researchers have highlighted the limitations of traditional kidney function measurements. Serum creatinine (sCr) levels may not accurately detect significant loss of kidney function, especially in subclinical chronic kidney disease (sCKD) cases. The study used fluorescein isothiocyanate (FITC)-labelled sinistrin to measure glomerular filtration rate (GFR) and kidney function. It revealed that sCKD reduced GFR by 20% but decreased kidney function (KFR) by 50%. After ischemia-reperfusion injury (IRI), GFR fluctuated, but KFR remained relatively stable in sCKD. Serum creatinine and creatinine clearance were unreliable indicators, except immediately after IRI. Urine damage biomarkers proved valuable in retrospectively detecting sCKD.
Like
Save
Share